Adults in early opioid/stimulant recovery describe cannabis as a helpful substitution strategy | Research

The takeaway

Fourteen adults who increased cannabis use after resolving opioid or stimulant addictions described it as an effective strategy for managing withdrawal, cravings, and psychiatric symptoms, while still experiencing typical recovery benefits.

People in early recovery considering cannabis, addiction counselors, harm reduction advocates

All reported typical recovery benefits with cannabis use

What the researchers found

Participants found cannabis appealing for its safer profile (no overdose risk, safe supply, few side effects). Primary motives: psychiatric symptom management, withdrawal/craving mitigation, boredom relief. All described typical recovery benefits (improved self-concept, better relationships) while using cannabis. Some negative effects noted: decreased productivity, social anxiety.

Why it matters

The addiction field's focus on abstinence has limited understanding of non-abstinent recovery. If cannabis substitution helps some people sustain recovery from more dangerous substances, harm reduction frameworks may need to accommodate this reality.

The numbers in context

14 participants (8 men, 6 women). 11 resolved opioid addictions, 3 resolved methamphetamine. Ages 20-50. All reported increased cannabis use during early recovery (within 12 months).

How the study worked

Grounded theory qualitative study with 14 participants (8 men, 6 women, ages 20-50) who resolved primary opioid (11) or methamphetamine (3) addiction and increased cannabis use within the previous 12 months. Semi-structured interviews analyzed through line-by-line, focused, and axial coding.

What this study cannot tell us

Very small sample. Self-selected participants who view substitution positively. No comparison to abstinent recovery or continued use groups. Qualitative design cannot measure outcomes. Early recovery only (within 1 year).

How to read the evidence

Small qualitative study provides rich individual perspectives but cannot generalize to broader populations or measure outcomes.

When this study was published

2024 qualitative study of adults in early recovery

The bigger picture

With fentanyl making opioid use increasingly lethal, pragmatic strategies that reduce overdose risk while supporting recovery deserve investigation. This study suggests cannabis substitution may work for some individuals, challenging the abstinence-only recovery paradigm.

Questions still open

Does cannabis substitution improve long-term recovery outcomes compared to abstinence? For whom does substitution work, and for whom might it lead to new problems? How do 12-step and other recovery communities respond to cannabis substitution?

Common questions

Can cannabis help with opioid recovery?

These 14 participants found cannabis helpful for managing withdrawal, cravings, and psychiatric symptoms during early recovery. However, this was a small, self-selected sample and cannot prove cannabis substitution works broadly.

Were there downsides to using cannabis in recovery?

Some participants reported decreased productivity and social anxiety from cannabis use, though they still described overall recovery benefits like improved relationships and self-concept.

Read the original research

"Everything is kind of the same except my mind is with me": exploring cannabis substitution in a sample of adults in early recovery from an opioid or stimulant addiction.

Harm reduction journal, 21(1), 83

View on PubMed ↗Publisher’s paper ↗

Citation

Beaugard, Corinne A; Walley, Alexander Y; Amodeo, Maryann. (2024). "Everything is kind of the same except my mind is with me": exploring cannabis substitution in a sample of adults in early recovery from an opioid or stimulant addiction.. Harm reduction journal, 21(1), 83. https://doi.org/10.1186/s12954-024-01002-0